Kwarlay.com

Navigating the News Maze with Clarity

    • Medicine

    FDA Approves Celltrion’s Stelara Biosimilar for Multiple Indications

    admin Posted on

    Approval of Steqeyma was based on a comprehensive evidence review, including a Phase III trial in moderate to severe plaque psoriasis.

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Slot
    TOGEL ONLINE